#Human Chorionic Gonadotropin (hCG) Market Share

[anujmrfr]

Human Chorionic Gonadotropin (hCG) Market Size, Growth Outlook 2035

The Human Chorionic Gonadotropin Market Size was estimated at 2.17 (USD Billion) in 2024. The Human Chorionic Gonadotropin Market Industry is expected to grow from 2.24 (USD Billion) in 2025 to 2.97 (USD Billion) till 2034, at a CAGR (growth rate) is expected to be around 3.17% during the forecast period (2025 - 2034).

Market Overview

The Human Chorionic Gonadotropin (hCG) Market is witnessing substantial growth due to the increasing prevalence of infertility disorders, hormonal imbalance conditions, and the rising demand for hormone-based therapies. hCG hormone plays a crucial role in reproductive health and is widely used for assisted reproductive technologies (ART), weight management treatments, and testosterone production enhancement. The growing adoption of fertility treatments, along with advancements in biopharmaceutical research, is driving market expansion.

The demand for hCG-based medications has been increasing in both fertility clinics and research laboratories, as the hormone is also used in diagnosing pregnancy complications and certain types of cancer detection. With the rise in obesity rates, the use of hCG diet plans has also gained attention, further contributing to the market's growth.

Market Size and Share

The Human Chorionic Gonadotropin MarketSize was estimated at 2.17 (USD Billion) in 2024. The Human Chorionic Gonadotropin Market Industry is expected to grow from 2.24 (USD Billion) in 2025 to 2.97 (USD Billion) till 2034, at a CAGR (growth rate) is expected to be around 3.17% during the forecast period (2025 - 2034).North America dominates the market due to the high prevalence of infertility treatments and the widespread use of hCG therapy in assisted reproductive technology (ART). The Asia-Pacific region is expected to grow significantly, driven by increasing awareness of reproductive health and government initiatives supporting fertility treatments.

Market Drivers

Rising Cases of Infertility: Increasing cases of infertility in both men and women due to lifestyle changes, stress, and medical conditions are fueling the demand for hCG hormone therapy.

Advancements in Assisted Reproductive Technology (ART): The growing adoption of in-vitro fertilization (IVF) and intrauterine insemination (IUI) procedures is boosting the use of hCG injections for improving fertility outcomes.

Growing Awareness of Hormone-Based Therapies: The increasing awareness about hormonal treatments for reproductive health, hypogonadism, and pregnancy complications is a key market driver.

Use of hCG in Cancer Detection and Treatment: The hormone is widely used for diagnosing and managing certain types of cancers such as testicular and ovarian cancer, increasing its application in oncology.

Weight Management and Metabolism Regulation: The use of hCG-based diet plans for weight loss treatments has gained popularity, contributing to market expansion.

Challenges and Restraints

Side Effects and Ethical Concerns: Some hCG-based treatments have been linked to adverse effects such as ovarian hyperstimulation syndrome (OHSS), mood swings, and allergic reactions, leading to regulatory scrutiny.

Stringent Regulatory Approvals: Regulatory authorities like the FDA and EMA impose strict guidelines on the use of hCG injections and therapies, impacting product approvals and commercialization.

Availability of Alternative Treatments: The presence of alternative fertility treatments and hormone therapies may limit the adoption of hCG-based solutions.

Market Trends

Rising Demand for Injectable hCG Products: The preference for injectable formulations over oral medications is increasing due to their higher bioavailability and effective results in fertility treatments.

Integration of Biotechnology in Hormone Therapies: Advances in biotechnology and genetic engineering are driving the development of recombinant hCG products with improved efficacy and safety.

Growing Focus on Personalized Medicine: The shift towards personalized hormone treatments based on individual patient profiles is gaining traction in fertility clinics and specialty hospitals.

Expansion of Fertility Clinics and ART Centers: The increasing number of specialized fertility clinics offering IVF and hormone therapies is positively impacting the market.

Regional Analysis

North America: The region dominates the market due to high healthcare expenditure, the presence of leading fertility clinics, and strong adoption of hCG-based fertility treatments.

Europe: Government initiatives supporting fertility awareness programs and hormone therapy research are contributing to market growth.

Asia-Pacific: Rising infertility rates, growing medical tourism for fertility treatments, and increasing investment in biopharmaceuticals are driving market expansion in this region.

Rest of the World: Emerging markets in Latin America and the Middle East are witnessing gradual adoption due to increasing access to fertility treatments and hormone-based therapies.

Segmental Analysis

By Product Type:

Natural hCG

Recombinant hCG

By Application:

Fertility Treatment

Weight Management

Cancer Diagnosis & Treatment

Hormone Therapy

By End-User:

Fertility Clinics

Hospitals & Specialty Clinics

Research Laboratories

Homecare

Key Market Players

Ferring Pharmaceuticals

Hetero Labs

Merck

LG Chem

Organon Co.

Aspen Pharmacare

Reddy's Laboratories

Lupin

Recent Developments

Innovations in Recombinant hCG Therapy: Companies are investing in genetically engineered hCG products with higher purity and stability for enhanced treatment outcomes.

Expansion of Fertility Treatment Centers: Leading pharmaceutical companies are collaborating with IVF clinics to increase hCG product distribution and accessibility.

Regulatory Approvals for New hCG Products: Recent FDA and EMA approvals for new hCG formulations are driving market expansion.

For more information, please visit us at marketresearchfuture.

[dennismartin]

How to Safely Buy Hucog 2000 IU Injections for Fertility and Health Treatments

When it comes to fertility treatments and hormonal therapies, one of the most widely used medications is HCG (Human Chorionic Gonadotropin). Among the many options available in the market, Hucog 2000 IU injections stand out for their effectiveness in assisting with ovulation in women and improving fertility in men. If you’re considering undergoing fertility treatment or need to address hormone imbalances, it is important to know how to buy Hucog 2000 IU injections safely and effectively.

What is Hucog 2000 IU Injections? Hucog 2000 IU injections are a form of Human Chorionic Gonadotropin (HCG), a hormone that naturally occurs during pregnancy. It is commonly used to trigger ovulation in women who are having difficulty getting pregnant or in assisted reproductive techniques like in vitro fertilization (IVF). HCG is also used in men to stimulate the production of testosterone and improve sperm count in cases of male infertility.

The HCG Hucog 2000 IU injections are typically prescribed in the treatment of infertility, whether it is for female ovulation induction or male hormonal imbalance. In women, this injection helps the ovaries release a mature egg, increasing the chances of pregnancy. For men, Hucog 2000 IU injections can increase testosterone levels and improve overall fertility.

Why You Should Buy Hucog 2000 IU Injections Choosing to buy Hucog 2000 IU injections offers several advantages, especially for those undergoing fertility treatments. Whether you’re using these injections as part of a fertility plan or to address hormonal imbalances, there are clear benefits to considering this option.

Convenience One of the biggest advantages of buying Hucog 2000 IU injections is the convenience it offers. Whether you're going through an IVF cycle or need a hormone boost, buying HCG Hucog 2000 IU injections allows you to receive the treatment at home without the need for constant clinic visits. This ease of access can make your treatment plan more manageable.

Privacy and Discretion For many individuals seeking fertility treatments, privacy is a top concern. Buying Hucog 2000 IU injections online allows you to maintain discretion and privacy throughout the process. Online pharmacies often ship products in discreet packaging, ensuring that no one will know about your treatment unless you choose to share it.

Cost-Effective Another reason to buy Hucog 2000 IU injections is the cost savings. Online platforms often offer better pricing compared to local pharmacies, especially if you are purchasing multiple doses for extended treatments. This can help you manage the financial aspect of fertility treatment, which can often be expensive.

How to Buy Hucog 2000 IU Injections Safely Although it is convenient to buy Hucog 2000 IU injections online, there are important precautions to take when doing so. Ensuring that you are buying from a trusted and reliable source is essential to receiving a safe and effective product. Here are some tips to help you purchase HCG Hucog 2000 IU injections safely:

Choose a Reputable Pharmacy Make sure to buy Hucog 2000 IU injections from a licensed and well-established pharmacy. Look for online pharmacies that are accredited and regulated by health authorities. You can often verify their legitimacy through customer reviews, their registration details, and their reputation in the medical community.

Consult Your Doctor First Before purchasing HCG Hucog 2000 IU injections, always consult your healthcare provider. Your doctor will assess your specific needs and determine whether this treatment is suitable for you. They will also guide you on the correct dosage, how to administer the injection, and monitor your progress throughout the treatment.

Check the Product’s Authenticity When you buy Hucog 2000 IU injections, ensure that the product is genuine and comes with proper packaging, expiration dates, and certification. Counterfeit or expired products can be ineffective or even harmful. Be sure to buy from trustworthy sources that offer authentic, high-quality products.

Look for Secure Payment Options Online security is important when purchasing medications. Make sure the website has secure payment methods, such as encrypted transactions and trusted payment processors. This ensures that your personal and financial details are protected.

Conclusion Hucog 2000 IU injections are an essential part of many fertility treatments, helping to trigger ovulation in women and improve hormonal balance in men. If you are considering using this treatment, buying Hucog 2000 IU injections online offers convenience, privacy, and cost savings. However, it is crucial to ensure that you are purchasing from a reliable, reputable pharmacy and following the advice of your doctor for safe and effective use. By taking these steps, you can confidently pursue your fertility goals and manage your health needs.

[soumyafwr]

Human Chorionic Gonadotropin (hCG) Market Overview, Size, Share and Forecast 2031

[omkarpatel]

Human Chorionic Gonadotropin (HCG) Market is Estimated To Witness High Growth Owing To Rise in Infertility Rates

Human chorionic gonadotropin or HCG hormone is produced during pregnancy in women. It supports the normal development of an egg in a woman's ovary, and the egg is released from the ovary during ovulation. HCG hormone is also used medically to stimulate ovulation and pregnancy in infertile women. The use of HCG hormone encourages the healthy development of the early stages of pregnancy. The Human Chorionic Gonadotropin (HCG) Market is estimated to be valued at US$ 710.88 Mn or Million in 2023 and is expected to exhibit a CAGR of 6.5% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market key trends: The global HCG market is mainly driven by rising rates of infertility worldwide. In 2020, infertility was estimated to affect around 186 million people globally. Male infertility contributed to around 20-30% of infertility cases and female infertility contributed to 40-55% of cases. The remaining cases were due to combined problems or unknown causes. The rising infertility levels have led to increasing adoption of assisted reproductive technologies (ART) like HCG treatment. Besides this, increasing awareness about infertility treatment options and growing acceptability of HCG hormone for fertility treatment are fueling the growth of the human chorionic gonadotropin market. However, side effects associated with HCG therapy and availability of alternative therapies may hamper market growth over the forecast period. Porter’s Analysis Threat of new entrants: The Human Chorionic Gonadotropin (HCG) market requires high capital investment and has the presence of well-established players. This makes the threat of new entrants low. Bargaining power of buyers: Buyers have moderate bargaining power due to the availability of alternative products. However, the established therapies offer value to the patients. Bargaining power of suppliers: A few major suppliers dominate the raw material supply chain. This gives them moderate bargaining power. Threat of new substitutes: The Threat from substitutes is moderate as alternate established therapies offer comparable effectiveness. Competitive rivalry: The competition is high among existing players. SWOT Analysis Strength: Wide application areas and proven benefits of HCG Drive demand. Established distribution channels of major players. Weakness: Strict regulations and compliance requirements add production costs. Short shelf life is a concern. Opportunity: Increasing fertility disorders prevalence provides untapped growth potential regions. Novel drug delivery methods can boost customer acceptance. Threats: Price erosion due to patent expiries and entry of biosimilars. Stringent manufacturing practices up costs. Key Takeaways The global Human Chorionic Gonadotropin (HCG) market is expected to witness high growth, exhibiting CAGR of 6.5% over the forecast period, due to increasing prevalence of fertility-related issues. Advancements in assisted reproductive technologies and rising disposable income also support the market expansion. Regionally, North America dominated the HCG market in 2023 with over 30% revenue share owing to well-developed healthcare infrastructure and growing healthcare spending. Asia Pacific is anticipated to exhibit fastest growth during 2023-2030 induced by surging medical tourism, rising focus on infertility treatments, and growing generic drugs market in India and China. Key players operating in the Human Chorionic Gonadotropin market are Merck & Co., Inc., Ferring B.V.,Fresenius SE & Co.KGaA,Lupin,Sun Pharmaceutical Industries Ltd,Lee BioSolutions,Serum Institute of India Pvt. Ltd., Scripps Laboratories,Sanzyme Biologics Pvt. Ltd.,VHB Medi Sciences Limited, Bharat Serums And Vaccines Limited (BSV), Zydus Lifesciences Ltd, Corona Remedies Pvt. Ltd.

[nidarsanafwr]

https://meetupss.com/read-blog/51160_global-human-chorionic-gonadotropin-hcg-market-overview-size-share-and-forecast.html

Global Human Chorionic Gonadotropin (hCG) Market Overview, Size, Share and Forecast 2031

[gauricmi]

Human Chorionic Gonadotropin (HCG) Market: Rising Demand and Future Growth Prospects

A) Market Overview:

The global Human Chorionic Gonadotropin (HCG) market is estimated to be valued at US$ 710.88 million in 2022 and is expected to exhibit a CAGR of 6.5% over the forecast period of 2022-2030. HCG is a hormone produced during pregnancy and is widely used in fertility treatments and weight loss therapies. The market is driven by the increasing prevalence of infertility, growing awareness about HCG therapies, and advancements in medical technology and drug delivery systems.

B) Market Key Trends:

One of the key trends in the HCG market is the rising demand for HCG in fertility treatments. Infertility is a growing concern globally, and HCG injections are commonly used in assisted reproductive technologies to induce ovulation in women and enhance the chances of pregnancy. The increasing number of infertility cases, along with the success rate of HCG therapies, is fueling the demand for HCG products in the market.

For instance, Merck & Co., Inc., one of the key players in the HCG market, offers Pregnyl, a highly effective HCG drug used for the treatment of infertility. Pregnyl has shown promising results in inducing ovulation and supporting pregnancy, contributing to the growth of the market.

C) Porter's Analysis:

- Threat of new entrants: The Human Chorionic Gonadotropin (HCG) Market Size poses a moderate threat to new entrants due to the presence of established players with strong brand identities and a wide product portfolio.

- Bargaining power of buyers: The buyers in the HCG market have a moderate bargaining power, as there are several alternatives available in the market. However, the unique benefits and effectiveness of HCG products provide a competitive advantage to the suppliers.

- Bargaining power of suppliers: The suppliers in the HCG market have a moderate bargaining power, as there are multiple suppliers available in the market. However, the quality and reliability of HCG products are crucial factors for buyers, giving suppliers a strong position.

- Threat of new substitutes: The threat of new substitutes in the HCG market is low, as HCG is a unique hormone with specific therapeutic benefits that cannot be easily replaced.

- Competitive rivalry: The competitive rivalry in the HCG market is high, with several key players competing for market share. These players focus on product innovation, partnerships, and strategic collaborations to gain a competitive edge.

D) Key Takeaways:

- The global HCG market is expected to witness high growth, exhibiting a CAGR of 6.5% over the forecast period, due to increasing infertility cases worldwide and the effectiveness of HCG therapies. - North America is expected to dominate the HCG market, owing to advanced healthcare infrastructure, high awareness about fertility treatments, and favorable insurance reimbursement policies. - Key players operating in the global HCG market include Merck & Co., Inc., Ferring B.V., Fresenius SE & Co.KGaA, Lupin, Sun Pharmaceutical Industries Ltd, and others. These players focus on research and development, product launches, and acquisitions to strengthen their market position.

In conclusion, the global Human Chorionic Gonadotropin (HCG) market is poised for significant growth in the coming years. The rising demand for fertility treatments and the effectiveness of HCG therapies are driving market growth. Moreover, strategic initiatives by key players and advancements in medical technology are expected to further propel the market's expansion.

[ramkumarss]

Male Infertility Treatment Market size was valued at USD 4.3 billion in 2022 and is poised to grow at a significant CAGR of 4.93% from 2023-2029. male infertility refers to the inability of male to cause pregnancy in a fertile woman. A variety of the problems ranging from hormonal disturbances to physical, psychological problems can cause male infertility. Hormonal problems include hyperprolactinemia, hypothyroidism, panhypopituitarism and others. Physical problems include varicocele, torsion, damaged sperm ducts and others. Furthermore, Erectile dysfunction, premature ejaculation and ejaculatory incompetence may lead to male infertility. Although many treatments are available for male infertility, in many cases treatment will not work. In many of the cases, male infertility is caused by testicular damage that leads to the inability of sperm production. In addition, low sperm production and poor sperm quality are also major causes of male infertility. Drugs, hormonal therapy, and assisted reproductive technology make up the global male infertility treatment market (ART). Clomiphene citrate and tamoxifen are two drugs used to treat male infertility. Human chorionic gonadotropin hormone (hCG) and recombinant follicle stimulating hormone (rFSH) are two types of hormone therapy (rFSH). Patients are given gonadotropin treatment to increase their testosterone levels. If these medicines do not work after 6 to 12 months of treatment, assisted reproductive technologies may be a possibility. In vitro fertilization-embryo transfer (IVF-ET), gamete intrafallopian transfer (GIFT), frozen embryo transfer (FET), and zygote intrafallopian transfer (ZIFT) are the several types of assisted reproductive technologies (ZIFT). Request Sample : https://www.precisionbusinessinsights.com/request-sample/?product_id=18404

[market-insight-2023]

Global Endocrine Testing Market to Witness Growth in Coming Years

The new assessment focuses on Endocrine Testing Market submitted by the The Brainy Insights organization and considers commercial and basic market designs with recorded and measured market data. Endocrine Testing is anticipated to grow at a stunning CAGR of 6%, thereby garnering a revenue of USD 17.84 billion in the 2022-2030 timeframe. This research aims to give global Endocrine Testing market strategic & knowledge insights to assist in making informed investment decisions, decision making, and recognizing potential growth possibilities. The study report gives complex dynamics about the various aspects of the Endocrine Testing market, which assists organizations operating in the market make strategic development decisions. Additionally, the driving factors that are positively impacting the demand for Endocrine Testing market and restricting factors that are hampering the growth of Endocrine Testing market are discussed in detail, coupled with their influences on the Endocrine Testing market. The research delivers insights on the COVID-19 outbreak considering the alteration in customer demand & behaviour, re-routing the supply chain, purchasing patterns, major interventions of governments, and the dynamics of current market forces. This record will comprise all the significant aspects of the Endocrine Testing market, such as pros & cons, competition, openings, technological developments, regional analysis, etc.

Get the inside scoop with Sample report @ https://www.thebrainyinsights.com/enquiry/sample-request/12529

Further, the report provides a visual description of how all the organizations stand relatively based on their global Endocrine Testing market hold, geographic presence, competencies, employee & financial strength, and years of operations. Additionally, the SWOT analysis describes strengths, weaknesses, opportunities/possibilities, and threats that assist in accumulating the entire document with high efficiency & dependence. The report is an in-depth analysis of a wealthy supply of main factors responsible for developing the global Endocrine Testing market. The top-down & bottom-up strategies have been used to validate and estimate the market size of Endocrine Testing industry to evaluate the extent of multiple other dependent submarkets in the overall market.

Moreover, the report customization is done per the requirements of the clients. The study provides an in-depth analysis of each parameter, allowing our users to identify the most likely and perhaps the best trend in the current landscape. The companies are analyzed for both external and internal factors. The internal factors consist of the R&D base, consumer base, labour force, supply chain, market share in specific regions, and availability of technologies. The external factors include laws concerning product approval, per capita income, economic fluctuations, the performance of the industry in specific regions, and various other socio-economic parameters. The global Endocrine Testing market record provides a comprehensive analysis of the growth among segments & provides precise calculations & forecasts for sales by application and type in terms of value & volume.

Check complete table of contents with list of table and figures @ https://www.thebrainyinsights.com/report/endocrine-testing-market-12529

Based on the following items' applicability: Hospitals, Physicians Offices, Health Care Centers, Commercial Laboratories

The market segment by product type: Follicle stimulating hormone(FSH), Human Chorionic Gonadotropin (hCG), Thyroid Stimulating Hormone(TSH), Dehydroepiandrosterone sulfate (DHEAS), Prolactin, Progesterone, Insulin, Cortisol, Testosterone, Estradiol(E2), Luteinizing Hormone (LH)

The geographical portions of the report are as follows: North America (United States, Canada and Mexico), Europe (Germany, France, United Kingdom, Russia, Italy and Rest of Europe), Asia Pacific (China, Japan, Korea, India, Southeast Asia and Australia), South America (Brazil, Argentina, Colombia and Rest of South America), Middle East and Africa (Saudi Arabia, United Arab Emirates, Egypt, South Africa and Rest of the Middle East and Africa)

The study's goal is to identify the following crucial global market participants: Quest Diagnostics, Thermo Fisher Scientific, Siemens Healthcare, Ortho Clinical Diagnostics, bioMerieux, Agilent Technologies, Abbott Laboratories, Thermo Fisher Scientific, Beckman Coulter, Inc, BioRad Laboratories, AB Sciex, F-Hoffmann La Roche AG, , LabCorp

The study report gives penetrations from market positioning & marketing channels to likely growth approaches, providing in-depth analysis for new players or existing contestants worldwide Endocrine Testing industry. The report compromises many graphs and flowcharts that distinctly explain the attractiveness of each segment globally and in various regions. The research document has comprehensively used the figures & numbers with the help of graphical & pictorial representation, which represents extra clarity on the global Endocrine Testing market.

Have Any Query? Ask Our Expert @ https://www.thebrainyinsights.com/enquiry/request-customization/12529

About The Brainy Insights:

The Brainy Insights is a market research company, aimed at providing actionable insights through data analytics to companies to improve their business acumen. We have a robust forecasting and estimation model to meet the clients' objectives of high-quality output within a short span of time. We provide both customized (clients' specific) and syndicate reports. Our repository of syndicate reports is diverse across all the categories and sub-categories across domains. Our customized solutions are tailored to meet the clients' requirement whether they are looking to expand or planning to launch a new product in the global market.

Contact Us

Avinash D

Head of Business Development

Phone: +1-315-215-1633

Email: sales@thebrainyinsights.com

Web: www.thebrainyinsights.com

[nerdierthany0u-blog]

Human Chorionic Gonadotropin (HCG) Market Is Likely To Grow At The Uppermost CAGR During The Forecast Period 2018-2026

Human chorionic gonadotropin hormone (HCG) is a hormone secreted by the placenta after implantation of a fertilized zygote in the uterus. The hormone also supports normal development of an egg and helps in the stimulation of egg release from the ovary. The HCG is mainly used to induce ovulation in the women under infertility treatment. It is also used among males mostly to increase the sperm count and in young boys, due to pituitary gland disorders and other diseases, due to which the testicles of the young males does not drop down naturally into the scrotum.

The key players operating the global human chorionic gonadotropin market include Merck & Co., Inc., EMD Sereno, Inc., Fresenius Kabi, Bristol Myers Squibb Company, Ferring BV, and Kamia Biomedical Company. Acris Antibodies developed a human chorionic gonadotropin hormone by recombinant DNA technology that helps to prevent the disintegration of the corpus luteum of the ovary thereby, maintaining levels of progesterone production for healthy pregnancy in females.

Request for the Customization Of the Business Report @ https://www.coherentmarketinsights.com/insight/request-customization/1011

The HCG is usually administered as an injection under the skin into a muscle. The HCG can also be administered at home under the advice of a gynecologist or a pharmacist. The HCG levels can be determined with the help of urine or blood test. Result of specific test helps in the determining accurate measurement of the levels. These tests are mostly used to identify and confirm pregnancy or as a screening test to determine birth defects.

This primarily owes to the rising number of infertility cases as well as hormonal dysfunction among young males and females as a result of changing lifestyle. According to Mayo Clinic, around 25% of women fertility problems in the U.S. are a result of ovulation issues that are mostly caused due to dysfunction of human chorionic gonadotropin (HCG) hormone. 

[davidwalker2504]

Endocrine Testing Market Size, Share, Growth And Forecast To 2024

Global Endocrine Testing Market is expected to reach USD 13.02 billion by 2024. The endocrine system is a combined system that contains numerous glands situated throughout the body. Together with the nervous system, the endocrine system regulates and controls several internal physical functions. Although the nervous system uses nerve impulses as a means of control, the endocrine system uses chemical messenger molecules called hormones. With the help of network of glands, hormones are produced, stored, and secreted.

Thymus, adrenal glands, testes, hypothalamus, pituitary gland, ovaries, pineal gland, islet cells in the pancreas, thyroid, and parathyroid are glands of endocrine system. The endocrine testing market is estimated to grow at a significant CAGR of 8.0% over the future period as the scope and its applications are rising enormously across the globe.

Download Free Sample Report @ https://www.millioninsights.com/industry-reports/endocrine-testing-market/request-sample

Endocrine testing industry is segmented based on test type, technology, end use, and region. Insulin, estradiol (E2), cortisol, Follicle Stimulating (FSH), prolactin, Human Chorionic Gonadotropin (hCG), Thyroid Stimulating Hormone (TSH), Luteinizing Hormone (LH), testosterone, Dehydroepiandrosterone sulfate (DHEAS), progesterone, and other test type could be explored in endocrine testing market in the forecast period.

Thyroid Stimulating Hormone (TSH) sector accounted for the largest market share of endocrine testing industry and is estimated to lead the overall market in the coming years. This may be because of rising awareness regarding cardiovascular disorders and thyroid hormones levels. Moreover, insulin test is estimated to grow at fastest pace in the coming years, as growing diabetic population.

Highly used enhanced technology includes clinical chemistry, tandem mass spectrometry, sensor technology, immunoassay, monoclonal & polyclonal antibody technologies, and others that could be explored in the future period. During foremost period, the tandem mass spectrometry is estimated to lead the overall market. This may be because of rising use in combination with liquid chromatography. However, sensor technology segment is estimated to grow at fastest pace in the years to come, as rising use of biosensors in glucose monitoring for diabetes.

The market may be categorized based on end users like ambulatory care centers, hospital, commercial laboratory, and others could be explored in the foremost period. The hospital sector accounted for the largest market share and is estimated to continue its dominance in the forecast period. However, the commercial laboratory sector is estimated to grow at fastest pace in the coming years, as presence of skilled workers and accessibility of enhanced infrastructure.

Globally, North America accounted for the largest market share of endocrine testing and is estimated to continue its dominance in the upcoming years. The reason behind the overall market growth could be presence of advanced tertiary, secondary, and primary care hospitals, government initiative, enhanced compensation network, satisfactory government funding policy, and rising health awareness. Instead, Europe and the Asia Pacific are also estimated to have a positive influence on the future growth.

Europe is the second largest region with significant market share. However, Asia Pacific is estimated to grow at fastest pace with the highest CAGR of 9.1% in the foremost period. The aspects that may be ascribed to the growth comprise rising R&D expenditure by private agencies and government to improve therapeutic and diagnostic areas in the region. The developing countries like India and China are the major consumers of endocrine testing industry in this region, as developing healthcare infrastructure and government compensation policies.

The key players of endocrine testing market are Quest Diagnostics, Abbott Laboratories, LabCorp., AB Sciex, Hoffmann-La Roche Ltd., Agilent Technologies, DiaSorin, Biomedical Technologies, Bio-Rad Laboratories, and bioMerieux SA. These players are concentrating on inorganic growth to sustain themselves amongst fierce competition. As such, mergers, acquisitions, and joint ventures are the need of the hour.

Browse Full Research Report with TOC @ https://www.millioninsights.com/industry-reports/endocrine-testing-market

Market Segment:

Test Type Outlook (Revenue, USD Million, 2013 - 2024) • Estradiol • FSH • hCG • LH • DHEAS • Progesterone • Testosterone • TSH • Prolactin • Cortisol • Insulin • Others

Technology Outlook (Revenue, USD Million, 2013 - 2024) • Tandem Mass Spectrometry • Immunoassay • Monoclonal & Polyclonal antibody technologies • Sensor technology • Clinical chemistry • Others

End Use Outlook (Revenue, USD Million, 2013 - 2024) • Hospital • Commercial Laboratory • Ambulatory Care Centers • Others

Regional Outlook (Revenue, USD Million, 2013 - 2024) • North America • U.S. • Canada • Europe • UK • Germany • Asia Pacific • Japan • China • Latin America • Brazil • Mexico • MEA • South Africa

Continued…

Get in Touch At Million Insights, we work with the aim to reach the highest levels of customer satisfaction. Our representatives strive to understand diverse client requirements and cater to the same with the most innovative and functional solutions.

Contact Person: Ryan Manuel Research Support Specialist, USA Email: ryan@millioninsights.com

Global Headquarters Million Insights Felton Office Plaza 6265 Highway 9 Felton, California 95018, United States Phone: 1-408-610-2300 Email: sales@millioninsights.com Asia Pacific Million Insights Office No. 302, 3rd Floor, Manikchand Galleria, Model Colony, Shivaji Nagar, Pune, MH, 411016 India Phone: 91-20-65300184

[mrfrblogresearch02]

Point of Care Diagnostics/Testing Market Size  Analysis, Research Study 2027

Point of Care Diagnostics Market -Overview:

According to MRFR analysis, the global Point of Care Diagnostics Market Size is expected to register a CAGR of~11.6% from 2021 to 2027and hold a value of ~USD 36,740.3 million by 2027.

The medical equipment utilized to get an immediate result in examining various diseases, diabetes, cancer, heart diseases, are defined as point of care (POC) diagnostics. These devices include glucose monitoring kits, infectious disease testing kits, pregnancy and fertility testing kits, and drug abuse testing kits, to name a few.

The tests can be employed in a variety of circumstances, with each requiring a different course of action depending on the outcome. The drug screening kit can be used for several different purposes. In general, the test is used to determine whether or not a person has consumed any narcotic substance. Sportsmen and women can take the test to ensure that no narcotic substances are present before competing. The advent of portable POC devices supporting government policies is supplementing the POC diagnostics/testing market, with an increasing number of chronic conditions such as diabetes around the globe and a relatively small number of healthcare facilities in developing nations. In addition, market participants are introducing digital and wireless POC solutions to improve diagnosis efficiency and accuracy.

Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/10642 Regional Analysis: The market for point-of-care diagnostics is dominated by North America (which includes the United States and Canada). With the rising incidence and prevalence of lifestyle diseases, North America is gaining traction. More awareness of self-testing and home care goods and a considerable adoption of novel technologies are projected to play a crucial role in driving the point-of-care diagnostics market in North America. Healthcare product providers are merging and acquiring current market participants to extend their product availability across the region. Lacuna Diagnostics (US), a company that provides digital cytology point of care and telehealth services, was bought by Heska Corporation (US).

Owing to the limited availability of healthcare workers, various manufacturing facilities, changing demographics, and increasing consumer healthcare expectations, the Asia-Pacific point of care diagnostics/testing market is expected to be the fastest-growing market sector. Furthermore, comforting government rules, significant funding by industry participants, and innovative technically advanced solutions are all elements boosting the point of care diagnostics/testing market.

Segmentation: The global point of care diagnostics/testing market is categorized into product, end user, mode of purchase, and platform. Based on the product category, the market has been segregated into glucose monitoring, pregnancy & fertility testing, infectious disease testing, drug abuse testing, coagulation monitoring, cardiometabolic monitoring, cancer/tumor marker testing, hematology testing, urinalysis testing, cholesterol, and others. The glucose monitoring segment is expected to hold a considerable share of the market in 2020. Increasing POC urine hCG (Human Chorionic Gonadotropin) tests to diagnose pregnancy is fueling the market growth. Companies such as Abbott (US) are offering total β-hCG for the early detection of pregnancy. In addition, rising POC testing for early tumor detection is strengthening the demand for POC diagnostic products.

Based on end user, the global point of care diagnostics/testing market has been classified as hospitals & clinics, diagnostics centers, homecare/self-testing, and others. Hospitals &clinics held the largest segment share in 2020, owing to easy maneuvering, sample processing, and quick delivery of results. A laboratory information system also manages and stores patient’s test data for further reference, which further drives the market growth. Additionally, the demand for homecare/self-testing is accelerating due to increasing health risks during the pandemic outbreak and rising connectivity between patients and health care providers.

Based on mode of purchase, the global point of care diagnostics/testing market has been classified as over-the-counter (OTC) testing products and prescription-based testing products. The OTC testing products aim to hold a larger market share in the mode of purchase category. OTC products are sold without the prescription for generic disease-diagnosed patients. Theycomply with certain parameters that include the highest standards for efficacy and safety, Good Manufacturing Practice (GMP) manufacturing, stability testing, and labeling under 21 CFR 201.66. According to the FDA, over 300,000 marketed OTC drug products are categorized into 80 therapeutic classes. The largevariety and availability of the products are driving the point of care diagnostics/testing market.

Based on the platform, the global point of care diagnostics/testing market has been classified as immunoassays, molecular diagnostics, dipstick, and others. Immunoassays is estimated to hold the largest segment share in 2020, owing to the increasing demand forthe products for testing particular antibodies or a specific antigen in blood or other body fluids. The immunoassays-based POC test is carried out in countries with low resources and facilities. Among the immunoassays, lateral flow immunoassays are highly used for quick diagnosis as they are sensitive to specific antigens and offer quick & accurate results.

Key Players:

Some of the key players in the global point of care diagnostics/testing market are Abbott Laboratories (US), Siemens Healthineers GmbH (Germany), Chembio Diagnostics, Inc. (US), F. Hoffmann-La Roche Ltd (Switzerland), Johnson & Johnson Services, Inc. (US), Becton, Dickinson and Company (US), Danaher Corporation (US), PTS Diagnostics (US), Nova Biomedical (US), Quidel Corporation (US), Sekisui Diagnostics (US), Trinity Biotech (Ireland), AccuBioTech Co., Ltd.(China), Instrumentation Laboratory Company (Werfen) (US), and EKF Diagnostics Holdings plc (UK) among others.

Browse Detailed TOC with COVID-19 Impact Analysis at:

https://www.marketresearchfuture.com/reports/point-of-care-diagnostics-testing-market-10642

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 628 258 0071

Email: sales@marketresearchfuture.com

[soumyafwr]

https://www.articlefloor.com/human-chorionic-gonadotropin-hcg-market-overview-size-share-and-forecast-2031/

Human Chorionic Gonadotropin (hCG) Market Overview, Size, Share and Forecast 2031

[healthcare-market]

Digital Pregnancy Test Kits Market Size will Grow at a Robust Pace through 2025

Global Digital Pregnancy Test Kits Market: Introduction

Pregnancy test is an indicative marker test for determination of pregnancy, which measures the human chorionic gonadotropin (HCG) in urine samples. The HCG hormone is present in the human body only during pregnancy, which makes it possible for the test to provide accurate results. Various types of pregnancy tests are available in the market. Home pregnancy test (HPT) is the most common, which offers benefits of pregnancy testing at home, without the need to visit a physician or gynecologist. Recent technological advancements in home pregnancy tests have led to the emergence of digital pregnancy test kits. These test kits offer quick results in a digital format (pregnant / not pregnant), which eliminates the need for interpretation of results by women, thereby improving accuracy of the test.

Request a Sample of Digital Pregnancy Test Kits Market: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=46299

Key Drivers of Global Digital Pregnancy Test Kits Market

Increase in birth rate

Pregnancy and birth rates among teenagers in the U.S. are significantly high. Decline in birth rates and increase in life expectancy have resulted in a global shift in the population age distribution. Changes in the birth rate can come about not only because of changes in age-specific fertility rates, but also because of structural changes in the population. According to Theoretical Population Biology, even though birth rates are dropping across the world, due to increase in food security, affluence, and urbanization, the world's population is estimated to exceed 8 billion (up from 6.5 billion presently) by 2030, and could reach 9 billion by 2050.

Request a PDF Brochure - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=46299

Advantages of digital pregnancy test kits

Digital pregnancy test kits can estimate the result and the number of weeks a woman has been pregnant. The accuracy of the result is determined by the amount of visibility of the representation. Digital pregnancy tests provide accurate results, preventing the need to visit a health care professional.

Request for Analysis of COVID19 Impact on Digital Pregnancy Test Kits Market- https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=46299

North America to Account for Major Share of Global Digital Pregnancy Test Kits Market

North America dominated the digital pregnancy test kits market in terms of revenue in 2020, followed by Europe. Rise in adoption of new and advanced test kits owing to higher awareness among people about pregnancy test kits and adequate reimbursement policies for digital pregnancy test kits in the U.S., Canada, and countries in Europe are the major factors attributed to the regions' significant share of the global market. The market in Asia Pacific is projected to expand at a higher CAGR from 2021 to 2031, owing to higher pregnancy rate in emerging countries, such as China, India, and other countries in Southeast Asia, and rise in adoption of digital pregnancy test kits in these countries.

Enquiry before Buying Digital Pregnancy Test Kits Market Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=46299

Key Players Operating in Global Digital Pregnancy Test Kits Market

The global digital pregnancy test kits market is highly consolidated owing to the presence of small number of key players.

More Trending Reports by Transparency Market Research:

https://www.prnewswire.com/news-releases/increasing-adoption-of-targeted-cancer-therapies-to-propel-oncolytic-virus-immunotherapy-market-says-tmr-301347104.html

https://www.prnewswire.com/news-releases/initiatives-undertaken-by-various-countries-to-legalize-use-of-cannabis-for-medical-purposes-to-ensure-growth-of-medical-cannabis-market-says-tmr-301353174.html

https://www.prnewswire.co.uk/news-releases/growing-popularity-of-portable-mobile-systems-among-veterinary-practitioners-animal-stable-owners-to-expand-growth-potential-of-veterinary-radiography-system-market-notes-tmr-831702983.html

About Us Section:

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyse information. Now avail flexible Research Subscriptions, and access Research multi-format through downloadable databooks, infographics, charts, interactive playbook for data visualization and full reports through MarketNgage, the unified market intelligence engine. Sign Up for a 7 day free trial!

Contact Us

Rohit Bhisey Transparency Market Research, 90 State Street, Suite 700, Albany, NY 12207 Tel: +1-518-618-1030 USA – Canada Toll Free: 866-552-3453 Email: sales@transparencymarketresearch.com

Website: https://www.transparencymarketresearch.com/

[nidarsanafwr]

Global Human Chorionic Gonadotropin (hCG) Market Overview, Size, Share and Forecast 2031

[mrunalnerkarblog]

The presence of human chorionic gonadotropin (HCG) is commonly detected in early pregnancy tests.